<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05087680</url>
  </required_header>
  <id_info>
    <org_study_id>ACTPrEP</org_study_id>
    <nct_id>NCT05087680</nct_id>
  </id_info>
  <brief_title>An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South</brief_title>
  <official_title>An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rhode Island Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Mississippi Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rhode Island Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators will use a generalized framework for the adaptation of EBIs to inform the&#xD;
      development of a brief Acceptance and Commitment Therapy (ACT)-based culturally appropriate&#xD;
      pre-exposure prophylaxis (PrEP) intervention tailored to young Black men who have sex with&#xD;
      men (YBMSM), named ACTPrEP.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators will use a generalized framework for the adaptation of EBIs to inform the&#xD;
      development of a brief Acceptance and Commitment Therapy (ACT)-based culturally appropriate&#xD;
      pre-exposure prophylaxis (PrEP) intervention tailored to young Black men who have sex with&#xD;
      men (YBMSM), named ACTPrEP.&#xD;
&#xD;
        -  Specific Aim 1) Gather data from YBMSM (n = 20) and clinic staff (n = 10) through&#xD;
           in-depth interviews to assess quantitative measures, intervention design, and&#xD;
           experiences most relevant to PrEP engagement.&#xD;
&#xD;
        -  Specific Aim 2) Develop ACTPrEP utilizing Aim 1 data, working iteratively with experts,&#xD;
           and an intervention &quot;run through&quot; with a sample of participants.&#xD;
&#xD;
      Specific Aim 3) Evaluate ACTPrEP. Primary outcomes will be feasibility (measured by&#xD;
      percentage eligible, consented, randomized, and retained) and acceptability (measured by the&#xD;
      Client Satisfaction Questionnaire). Secondary outcomes will compare ACTPrEP vs. enhanced&#xD;
      standard of care condition (ESOC) on behavior outcomes (uptake, adherence, and PrEP&#xD;
      persistence) and possible mediators over the course of 24 weeks. Barriers and facilitators to&#xD;
      implementing ACTPrEP will be assessed with post-RCT qualitative interviews using the i-PARIHS&#xD;
      framework.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 25, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ACTPrEP Feasibility</measure>
    <time_frame>12 week visit</time_frame>
    <description>ACTPrEP feasibility is measured by percentage of participants retained in the study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ACTPrEP Acceptability</measure>
    <time_frame>12 week visit</time_frame>
    <description>Acceptability is measured with the Client Satisfaction Questionnaire.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>HIV Prevention</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group will include one 30-minute PrEP education session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ACTPrEP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ACTPrEP will include a 60-minute initial session and 30-minute sessions at 2, 6, and 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ACTPrEP</intervention_name>
    <description>ACTPrEP will include a 60-minute initial session and a series of 30-minute follow-up sessions. Sessions will focus on the Thoughts, Emotions, Associations, Memories, and Sensations (TEAMS) relevant to PrEP uptake and adherence.</description>
    <arm_group_label>ACTPrEP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enhanced Standard of Care</intervention_name>
    <description>Enhanced Standard of Care (ESOC) will include one 30-minute PrEP education session.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
          -  Between 18-34 years old&#xD;
&#xD;
          -  Male sex assigned at birth&#xD;
&#xD;
          -  Identify as African American/Black&#xD;
&#xD;
          -  Not enrolled in another PrEP related study&#xD;
&#xD;
          -  Able to give consent&#xD;
&#xD;
          -  Not taken PrEP in past 3 months&#xD;
&#xD;
          -  Report having sex with a man in the past 3 months&#xD;
&#xD;
          -  PrEP-eligible according to CDC guidelines&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participating in another PrEP study&#xD;
&#xD;
          -  Unable to provide consent&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>34 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Trisha Arnold, PhD</last_name>
    <phone>4017938701</phone>
    <email>trisha.arnold1@lifespan.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Larry Brown, MD</last_name>
    <email>larry_brown@brown.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Univeristy of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Trisha Arnold, PhD</last_name>
      <phone>401-793-8701</phone>
      <email>trisha.arnold1@lifespan.org</email>
    </contact>
    <contact_backup>
      <last_name>Lori Ward, PhD</last_name>
      <email>lward@umc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 13, 2021</study_first_submitted>
  <study_first_submitted_qc>October 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2021</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ACT</keyword>
  <keyword>PrEP</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

